In a 65‑year‑old man taking levothyroxine 100 µg daily who has a thyroid‑stimulating hormone (TSH) of 12 mIU/L and a free thyroxine (T4) of 1.2 µg/dL, what is the most appropriate initial management step?

Increase Levothyroxine Dose by 12.5–25 µg

In a 65-year-old man taking levothyroxine 100 µg daily with TSH 12 mIU/L and free T4 1.2 µg/dL, the most appropriate initial step is to increase the levothyroxine dose by 12.5–25 µg and recheck TSH in 6–8 weeks. 1

Current Thyroid Status

• This patient has inadequate thyroid hormone replacement, evidenced by TSH >10 mIU/L despite being on levothyroxine therapy 1
• The normal free T4 (1.2 µg/dL) with elevated TSH confirms subclinical hypothyroidism in a treated patient, indicating the current 100 µg dose is insufficient 1
• TSH >10 mIU/L carries approximately 5% annual risk of progression to overt hypothyroidism and is associated with cardiac dysfunction and adverse lipid profiles 1

Dose Adjustment Strategy

• Increase levothyroxine by 12.5–25 µg increments based on the patient's current dose and clinical characteristics 1, 2
• For this 65-year-old patient without specified cardiac disease, a 25 µg increment (to 125 µg daily) is appropriate 1
• If cardiac disease or multiple comorbidities are present, use the smaller 12.5 µg increment to avoid cardiac complications 1

Monitoring Protocol

• Recheck TSH and free T4 in 6–8 weeks after dose adjustment, as this represents the time needed to reach steady state 1, 2
• Target TSH should be within the reference range of 0.5–4.5 mIU/L with normal free T4 levels 1
• Continue dose adjustments every 6–8 weeks until TSH normalizes 1
• Once stable, monitor TSH every 6–12 months or sooner if symptoms change 1

Why Treatment Is Mandatory at This TSH Level

• TSH >10 mIU/L warrants dose adjustment regardless of symptoms, as this threshold is associated with significant cardiovascular risk and metabolic consequences 1, 3
• Treatment may improve hypothyroid symptoms and lower LDL cholesterol 1
• The patient is already on levothyroxine therapy, so the elevated TSH clearly indicates underdosing rather than a decision about whether to treat 1

Critical Pitfalls to Avoid

• Do not make excessive dose increases (e.g., jumping from 100 to 150 µg), as this risks iatrogenic hyperthyroidism with increased risk for atrial fibrillation, osteoporosis, and cardiac complications 1
• Do not recheck TSH before 6–8 weeks, as adjusting doses too frequently before reaching steady state leads to inappropriate management 1
• Do not ignore this TSH elevation—approximately 25% of patients on levothyroxine are unintentionally maintained on inadequate doses, perpetuating hypothyroid complications 1
• Ensure the patient takes levothyroxine on an empty stomach, 30–60 minutes before breakfast, and at least 4 hours apart from iron, calcium, or antacids, as absorption issues may contribute to inadequate response 1, 4

Special Considerations for This Patient

• At age 65, if cardiac disease is present, start with the lower 12.5 µg increment and monitor closely for angina, palpitations, or arrhythmias 1
• Before increasing the dose, briefly assess medication adherence and timing of administration, as non-compliance or improper timing accounts for many cases of apparent treatment failure 1, 2
• If TSH remains elevated after appropriate dose escalation and confirmed adherence, consider malabsorption, drug interactions (iron, calcium, proton pump inhibitors), or rare causes of high levothyroxine requirements 1, 5